Uncover key drivers, emerging technologies, and competitive movements shaping the circulating tumor cells market from 2025–2034 with trusted insights from The Business Research Company
How Is The Circulating Tumor Cells Market Size Expected To Expand Over 2029-2034?
The market for circulating tumor cells has experienced substantial expansion in recent years. This market is projected to expand from $11.9 billion in 2024 to reach $13.27 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 11.5%. Historically, this growth has been driven by factors such as the increasing incidence and prevalence of cancer, the clinical utility in cancer staging, the emergence of liquid biopsy techniques, patient demand for minimally invasive tests, regulatory support for liquid biopsies, and a strong focus on early cancer detection.
The circulating tumor cells market is projected to experience substantial expansion over the upcoming years, anticipating a rise to $21.38 billion by 2029, driven by a compound annual growth rate (CAGR) of 12.7%. This growth throughout the forecast period is attributable to point-of-care CTC testing, the increased adoption of microfluidics, a concentrated focus on rare cancer types, the standardization of CTC assays, the expansion of CTC-based clinical trials, and economic and emerging market growth. Prominent trends for the forecast period involve innovations in CTC isolation techniques, government funding allocated for CTC research, advancements in CTC detection technologies, the use of liquid biopsy for cancer monitoring, integration with single-cell analysis, and technological convergence with artificial intelligence (AI).
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp
Which Market Factors Are Fueling The Circulating Tumor Cells Industry Growth?
The expansion of the circulating tumor cells market is anticipated due to the increasing occurrence of cancer. Cancer is a condition where certain body cells proliferate uncontrollably and spread to other areas. Circulating tumor cells assist in the early identification and diagnosis of cancer, thus the rising prevalence of cancer fuels the growth of the circulating tumor cells market. For instance, in January 2023, the American Cancer Society Journals, a US-based voluntary health organization, projected 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States. Consequently, the growing incidence of cancer is a key driver for the circulating tumor cells market’s growth.
Which Categories Are Covered In The Circulating Tumor Cells Market Segmentation Analysis?
The circulating tumor cellsmarket covered in this report is segmented –
1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, Research
Subsegments:
1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits
2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes
3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems
Which Market Trends Are Expected To Define The Future Of The Circulating Tumor Cells Market?
Product innovation represents a pivotal trend gaining significant traction within the circulating tumor cells market. Key companies active in the circulating tumor cells market are concentrating on developing groundbreaking products to reinforce their market standing. An illustration of this is the launch of Celselect Slides 2.0 by Bio-Rad Laboratories, Inc., a US-based medical laboratory, in June 2024. This product is specifically designed to improve the capture of rare cells and circulating tumor cells (CTCs), thereby boosting the accuracy and efficiency of cell analysis in both clinical and research settings.
Which Organizations Are At The Forefront Of The Circulating Tumor Cells Market?
Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report
Which Geographic Areas Are Driving Strong Demand For The Circulating Tumor Cells Market?
North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp
Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2025, By The Business Research Company
Cardiovascular Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
Cardiovascular Surgery Devices And Equipment Global Market Report 2025
Spinal Surgery Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
